A further independent study (48) demonstrated an increased likelihood of cancer incidence (OR: 1.3; 95% CI: 1.0, 1.6), when comparing those with a baseline CRP level of < 1 mg/l, with those > 3 mg/l, although this interaction was not significant (p = 0.06). Here, CRP is linked to cancer.